14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of LUMO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Lumos Pharma Inc. stock upgraded from Sell Candidate to Hold/Accumulate after Thursday trading session.
(Updated on Apr 25, 2024)

Hold candidate since Apr 25, 2024 PDF

The Lumos Pharma Inc. stock price fell by -1.25% on the last day (Thursday, 25th Apr 2024) from $2.80 to $2.76. During the last trading day the stock fluctuated 3.56% from a day low at $2.71 to a day high of $2.81. The price has fallen in 5 of the last 10 days but is still up by 1.85% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -45 thousand shares and in total, 2 thousand shares were bought and sold for approximately $4.33 thousand.

The stock lies the upper part of a wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $2.83 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -12.96% during the next 3 months and, with a 90% probability hold a price between $2.09 and $2.47 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

LUMO Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, April 15, 2024, and so far it has risen 12.65%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Lumos Pharma Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $2.77. On a fall, the stock will find some support from the short-term average at $2.68. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Lumos Pharma Inc. stock

Lumos Pharma Inc. finds support from accumulated volume at $2.70 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0967 between high and low, or 3.56%. For the last week the stock has had daily average volatility of 6.35%.

Our recommended stop-loss: $2.65 (-3.98%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 8 days ago.)

Trading Expectations (LUMO) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Lumos Pharma Inc. to open at $2.76, and during the day (based on 14 day Average True Range), to move between $2.59 and $2.93, which gives a possible trading interval of +/-$0.172 (+/-6.25%) up or down from last closing price. If Lumos Pharma Inc. takes out the full calculated possible swing range there will be an estimated 12.50% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.70 (2.17%) than the resistance at $3.01 (9.06%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Lumos Pharma Inc. will release earnings BMO on Wednesday, May 01, 2024.The consensus among the analysts for the expected earnings (EPS) is -$1.21. We will update the financials statements for Lumos Pharma Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 10.47% in the first trading day after earnings release.

Is Lumos Pharma Inc. stock A Buy?

Lumos Pharma Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: -0.357 Hold/Accumulate Upgraded

Predicted Opening Price for Lumos Pharma Inc. of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$2.76 ( 0.0399%) $2.76

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for LUMO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.86 3.54 %
R2 2.82 2.21 %
R1 2.80 1.38 %
Current price: 2.76
Support S1 2.72 -1.30 %
S2 2.70 -2.13 %
S3 2.66 -3.46 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.05 10.51 %
R2 3.04 10.14 %
R1 3.01 9.06 %
Current price 2.76
Support S1 2.70 -2.17%
S2 2.65 -3.99%
S3 2.52 -8.70%

FAQ

What is the symbol for Lumos Pharma Inc. Stock and on which exchange is it traded?
The symbol for Lumos Pharma Inc. is LUMO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Lumos Pharma Inc. Stock?
Lumos Pharma Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Lumos Pharma Inc. Stock?
Lumos Pharma Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Lumos Pharma Inc. Stock.

What's the current price of Lumos Pharma Inc. Stock?
As of the end of day on the Apr 25, 2024, the price of an Lumos Pharma Inc. (LUMO) share was $2.76.

What is the 52-week high and low for Lumos Pharma Inc. Stock?
The 52-week high for Lumos Pharma Inc. Stock is $4.55 and the 52-week low is $2.41.

What is the market capitalization of Lumos Pharma Inc. Stock?
As of the Apr 25, 2024, the market capitalization of Lumos Pharma Inc. is 22.376M.

When is the next earnings date for Lumos Pharma Inc.?
The upcoming earnings date for Lumos Pharma Inc. is May 01, 2024.
Click to get the best stock tips daily for free!

About Lumos Pharma Inc.

Lumos Pharma. Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas.... LUMO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT